Cost is a common barrier to medication adherence. The authors discuss the potential role of medication rebates in patients’ out-of-pocket costs and medication adherence.
Helene Vilme, DrPH
Advertisement
Articles by Helene Vilme, DrPH
Advertisement
Latest Updated Articles
- Potential Impact of Pharmaceutical Industry Rebates on Medication Adherence
Published: April 29th 2019 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Expands Evinacumab-dgnb Approval for Children as Young as 1 Year With HoFH
2
In Primary Care–Oncology Collaboration, the Baton Goes Both Ways
3
FDA Approves Imlunestrant for ER+ and HER2-Negative Breast Cancer
4
Trust and Transparency Key for Leveraging AI to Expand Access to Precision Oncology
5
